平安好醫生、京東健康及阿裏健康漲逾6%至9% 互聯網醫院於本輪疫情就診量飆升
內地互聯網醫院於本輪新冠疫情中崛起,不少上海市民藉助互聯網醫院提供的線上就醫等相關服務,令處方量按年增逾十倍,行業未來發展可期。於本港上市的相關股今天(13日)跑贏大市,其中藍籌阿裏健康(00241.HK)重越10天線(4.03元),午後高見4.09元,現報4.08元,回升9.7%,成交增至5,895萬股,爲升幅最大藍籌。
平安好醫生(01833.HK)高見17.18元,現報17.08元,回升6.2%;京東健康(06618.HK)更三連升,今日股價升破10天線(44.4元),午後升幅擴至8.2%報45.05元,成交已達795萬股。
上海市衛生健康委表示,自4月1日以來,上海市互聯網醫院業務診療量明顯增加,服務總人次爲去年同期5.2倍,處方量更爲去年同期11.2倍。通過互聯網醫院分流了百姓看病配藥需求,緩解了醫院救治壓力,減少人員集聚,降低交叉感染風險。
恆指午後高見19,865,現報19,812,回升430點或2.2%,成交額808億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.